BUMC Transgender Medicine Research Group

Transgender individuals have unique healthcare needs, particularly those who elect to receive hormone therapy and/or gender confirmation surgery. However to-date, very little research has been conducted on important health topics for transgender individuals that genuinely addresses their healthcare concerns and outcomes.

Joshua D. Safer, M.D., FACP, Director, Endocrinology Fellowship Training Program is engaged in clinical research to address this critical lack of knowledge on medical topics regarding transgender-identified individuals.

Our research emphasis is on improving the current medical knowledge on health topics that specifically impact the transgender community, with the goal of continually improving the health and outcomes of transgender individuals who receive medical care. Our BUMC Transgender Research Group affirms the right of all individuals to be able to discuss their health concerns with practitioners who are knowledgeable and respectful towards a patient’s unique, identity-specific needs.

Click below for more information on current published research in the below topics:

- Practical guidelines for transgender hormone treatment

- Evidence that gender identity is not reversible

- Increasing transgender health education in medical students’ curricula 

Additionally, our work includes the development of a Transgender Health Registry at BMC, in which all transgender-identified individuals who have had hormone therapy or other transgender health care management at Boston Medical Center (BMC) who give consent to participate will have information relevant to their transgender medical care recorded in a registry. It is our hope that by establishing the first BMC registry of Transgender Health, we will be able to better serve individuals who identify as transgender within our community both now and in the future.

Contact|Directory|BUMC
December 27, 2013
Primary teaching affiliate
of BU School of Medicine